Alector, Inc.

ALEC Healthcare Biotechnology

Alector, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $21.0 million, down 79.1% from fiscal 2024. In the quarter to June 2026, revenue fell 57.8%, EPS grew 30.0%, free cash flow grew 30.2% and total debt rose 3.27%, each against the same quarter a year earlier.

1.84 0.07 −3.66%
Market cap
$213.3M
P/E
0.0×
Fwd P/E
−1.9×
Dividend yield
—
F-score
1/9
Altman Z
−5.15
Beneish M
n/a
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
16.13 12.91 7.64 4.40
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(6.53) (4.77) (3.85) (9.34)
P/B ratio
0.00 22.90 5.24 5.26
Price to Tangible BV
0.00 22.90 5.24 5.26
EV/Sales
4.97 2.23 (4.07) 0.44
EV/EBITDA
0.00 0.00 0.56 0.00
EV/Operating CF
(0.44) (0.24) 0.47 (0.15)
EV/FCF
(0.43) (0.24) 0.47 (0.15)
Quick Ratio
5.05 5.04 3.68 3.64
Current Ratio
5.26 5.25 3.83 3.76
Net Debt/EBITDA
7.16 8.40 6.40 7.66
Debt/Assets
4.85% 4.07% 3.30% 2.87%
Debt/Equity
(0.99) 0.94 0.32 0.17
Asset Turnover
0.05 0.06 0.06 0.16
Operating CF/Net income
1.49 2.17 1.12 0.94
Capex/Depreciation
(0.02) (0.08) 0.00 (0.01)
Research and Development Expense of Revenue
586.14% 1,707.17% 520.49% 900.31%
Selling, General and Administrative Expense of Revenue
248.58% 775.14% 213.88% 353.31%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
78.61% 278.01% 77.65% 196.38%
Graham Net Nets
(0.15) (0.06) 0.02 0.08
Graham Number
1.49 0.00 0.00 0.00
Earnings Yield
(54.73%) (55.35%) (89.10%) (36.15%)
Free Cash Flow Yield
(70.85%) (72.84%) (114.56%) (65.06%)
Revenue per Share
0.03 0.01 0.06 0.03
Operating CF per Share
(0.31) (0.45) (0.40) (0.32)
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.31) (0.45) (0.40) (0.32)
Cash per Share
1.55 1.87 2.49 2.84
Shareholders Equity per Share
(0.09) 0.09 0.30 0.56
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
(0.09) 0.09 0.30 0.56
Free Cash Flow
(34.25) (49.93) (41.69) (32.52)
Working Capital
145.85 174.12 196.95 220.42
Capital Expenditures
(0.03) (0.12) 0.00 (0.01)
Net Current Asset Value
(32.74) (14.45) 3.86 22.81
EV/EBIT
0.00 0.00 0.55 0.00
Capex to Sales
0.01 0.11 0.00 0.00
Price to Operating Income
0.00 0.00 0.00 0.00
Other line items
Average Payables
2.25 1.87 1.95 4.89
Average Assets
279.64 324.11 380.77 425.65
Average Common Equity
30.60 52.50 78.72 88.32

Fold the line items

Columns are period end dates